TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/21 20:38 | 8/10/21 | SWTX | Springworks Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Bain Capital Life Sciences Investors, LLC | MA | T | S | -70,250 | 70.25 | 0 | -1,000 | -17 | 4,832 | I | |||||||||||||||
3/11/21 16:30 | 3/9/21 | SWTX | Springworks Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Bain Capital Life Sciences Investors, LLC | MA | T | S | -103,675 | 71.50 | 0 | -1,450 | -20 | 5,831 | I | |||||||||||||||
11/21/19 16:26 | 11/19/19 | DRNA | Dicerna Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Bain Capital Life Sciences Investors, LLC | MA | T | S | -38,553 | 22.03 | 0 | -1,750 | -24 | 5,580 | I | ||||||||||||||||
5/31/19 16:15 | 5/29/19 | DRNA | Dicerna Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Bain Capital Life Sciences Investors, LLC | MA | DT | S | -20,000 | 12.50 | 0 | -1,600 | -18 | 7,330 | I | |||||||||||||||
12/19/17 20:30 | 12/15/17 | MRNS | Marinus Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Bain Capital Life Sciences Investors, LLC | MA | T | S.m | -10,025 | 7.88 | 0 | -1,273 | -24 | 3,977 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |